SCHEMBL9707717

SCHEMBL9707717

COCCn1c(=O)[nH]c(=O)c2c1nc(C(C)C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.49
KDM4E B2RXH2 10/20 0.49
PKM P14618 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.46
RECQL P46063 1/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
HSD17B10 Q99714 4/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.44
HPGD P15428 5/20 0.43
MAPT P10636 3/20 0.43
HTT P42858 2/20 0.43
USP1 O94782 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707464 0.91 MEN1 (0.45) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL9708303 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EPKMSMN1; SMN2GAA
SCHEMBL9707482 0.90 ALDH1A1 (0.53) ALDH1A1KDM4EPKMSMN1; SMN2GAA
SCHEMBL9707643 0.89 MEN1 (0.48) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL9707871 0.89 ADORA3 (0.42) ALDH1A1KDM4EPKMMEN1KMT2A
SCHEMBL9707557 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EPKMSMN1; SMN2GAA
SCHEMBL9708130 0.88 CXCL8 (0.49) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL9708300 0.88 MEN1 (0.42) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL9707846 0.88 ALDH1A1 (0.49) ALDH1A1KDM4EPKMSMN1; SMN2GAA
SCHEMBL9708640 0.87 USP1 (0.42) ALDH1A1KDM4EPKMSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed